JM Gatell

1.3k total citations
28 papers, 805 citations indexed

About

JM Gatell is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, JM Gatell has authored 28 papers receiving a total of 805 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 13 papers in Virology and 10 papers in Emergency Medicine. Recurrent topics in JM Gatell's work include HIV Research and Treatment (13 papers), HIV/AIDS drug development and treatment (13 papers) and HIV/AIDS Research and Interventions (12 papers). JM Gatell is often cited by papers focused on HIV Research and Treatment (13 papers), HIV/AIDS drug development and treatment (13 papers) and HIV/AIDS Research and Interventions (12 papers). JM Gatell collaborates with scholars based in Spain, United Kingdom and Denmark. JM Gatell's co-authors include Jens Lundgren, Amanda Mocroft, Nathan Clumeck, Adriano Lazzarin, Elisa de Lazzari, Josep Mallolas, Montserrat Tuset, M. Martin, Bruno Ledergerber and Martin Fisher and has published in prestigious journals such as The Lancet, Clinical Infectious Diseases and European Respiratory Journal.

In The Last Decade

JM Gatell

26 papers receiving 778 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
JM Gatell Spain 13 593 354 282 255 50 28 805
Antoni Jou Spain 15 543 0.9× 484 1.4× 339 1.2× 232 0.9× 105 2.1× 23 904
Montserrat Tuset Spain 15 477 0.8× 167 0.5× 211 0.7× 135 0.5× 29 0.6× 50 799
Antonio Antela Spain 18 678 1.1× 362 1.0× 391 1.4× 330 1.3× 193 3.9× 49 947
Francesca Lombardi Italy 14 356 0.6× 243 0.7× 130 0.5× 124 0.5× 22 0.4× 72 563
N. Kumarasamy India 16 643 1.1× 356 1.0× 301 1.1× 185 0.7× 11 0.2× 21 772
Sean E Collins United States 15 636 1.1× 350 1.0× 204 0.7× 246 1.0× 26 0.5× 30 738
Valerianna Amorosa United States 18 375 0.6× 143 0.4× 346 1.2× 286 1.1× 332 6.6× 36 888
Maureen Wellington South Africa 15 884 1.5× 714 2.0× 196 0.7× 67 0.3× 12 0.2× 22 1.0k
Wisit Prasithsirikul Thailand 23 730 1.2× 331 0.9× 295 1.0× 238 0.9× 51 1.0× 54 997
Bernardino Roca Spain 14 232 0.4× 86 0.2× 153 0.5× 55 0.2× 42 0.8× 54 507

Countries citing papers authored by JM Gatell

Since Specialization
Citations

This map shows the geographic impact of JM Gatell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JM Gatell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JM Gatell more than expected).

Fields of papers citing papers by JM Gatell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by JM Gatell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JM Gatell. The network helps show where JM Gatell may publish in the future.

Co-authorship network of co-authors of JM Gatell

This figure shows the co-authorship network connecting the top 25 collaborators of JM Gatell. A scholar is included among the top collaborators of JM Gatell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with JM Gatell. JM Gatell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peraire, Joaquim, Miguel López-Dupla, Verònica Alba, et al.. (2015). HIV/antiretroviral therapy–related lipodystrophy syndrome (HALS) is associated with higher RBP4 and lower omentin in plasma. Clinical Microbiology and Infection. 21(7). 711.e1–711.e8. 8 indexed citations
2.
Domínguez-Rojas, Jesús, Montserrat Loncà, Arkaitz Imaz, et al.. (2015). Improvement of lipoatrophy by switching from efavirenz to lopinavir/ritonavir. HIV Medicine. 17(5). 340–349. 2 indexed citations
3.
Ryom, Lene, Ole Kirk, Jens Lundgren, et al.. (2013). Advanced chronic kidney disease, end‐stage renal disease and renal death among HIV‐positive individuals in Europe. HIV Medicine. 14(8). 503–508. 33 indexed citations
4.
Pérez, Ignacio, Mireia Junyent, Montserrat Laguno, et al.. (2012). Differences between HIV‐infected and uninfected adults in the contributions of smoking, diabetes and hypertension to acute coronary syndrome: two parallel case–control studies. HIV Medicine. 14(1). 40–48. 39 indexed citations
5.
Tuset, Montserrat, M. Martin, Elisa de Lazzari, et al.. (2011). Evaluation of antiretroviral-related errors and interventions by the clinical pharmacist in hospitalized HIV-infected patients. HIV Medicine. 12(8). 494–499. 51 indexed citations
6.
Martínez, Estebán, María Larrousse, D Podzamczer, & JM Gatell. (2009). Objective amount of limb fat in HIV‐infected subjects with subjective diagnosis of lipoatrophy. HIV Medicine. 10(4). 257–261. 6 indexed citations
7.
Martin, M., Elena del Cacho, Carles Codina, et al.. (2008). Relationship between Adherence Level, Type of the Antiretroviral Regimen, and Plasma HIV Type 1 RNA Viral Load: A Prospective Cohort Study. AIDS Research and Human Retroviruses. 24(10). 1263–1268. 122 indexed citations
8.
9.
10.
Mallolas, Josep, Pablo Labarga, Antonio Ocampo, et al.. (2007). Inhibitory quotient as a prognostic factor of response to a salvage antiretroviral therapy containing ritonavir‐boosted saquinavir. The CIVSA Study*. HIV Medicine. 8(4). 226–233. 8 indexed citations
11.
Mallolas, Josep, Judit Pich, Joan Albert Arnáiz, et al.. (2007). A randomized trial comparing the efficacy and tolerability of two HAART strategies at two years in antiretroviral naive patients. Revista Clínica Española. 207(9). 427–432. 6 indexed citations
12.
Bäuerle, Jochen, Montserrat Laguno, Stefan Mauss, et al.. (2005). Mitochondrial DNA depletion in liver tissue of patients infected with hepatitis C virus: contributing effect of HIV infection?. HIV Medicine. 6(2). 135–139. 17 indexed citations
13.
Florence, Éric, Felipe García, Montserrat Plana, et al.. (2004). Long-term Clinical Follow-up, without Antiretroviral Therapy, of Patients with Chronic HIV-1 Infection with Good Virological Response to Structured Treatment Interruption. Clinical Infectious Diseases. 39(4). 569–574. 7 indexed citations
14.
Martínez, Estebán & JM Gatell. (1999). Síndrome de lipodistrofia en personas infectadas por el virus de la inmunodeficiencia humana tipo 1. Endocrinología y Nutrición. 46(8). 269.
15.
Mocroft, Amanda, Sara Madge, Margaret Johnson, et al.. (1999). A Comparison of Exposure Groups in the EuroSIDA Study: Starting Highly Active Antiretroviral Therapy (HAART), Response to HAART, and Survival. JAIDS Journal of Acquired Immune Deficiency Syndromes. 22(4). 369–369. 122 indexed citations
16.
Gatell, JM. (1998). Early antiretroviral therapy: rationale, protease inhibitor-sparing regimens and once daily dosing.. PubMed. 3 Suppl 4. 49–53. 4 indexed citations
17.
Burke, Michael, Israel Yust, Christine Katlama, et al.. (1997). Cytomegalovirus retinitis in patients with AIDS in Europe. European Journal of Clinical Microbiology & Infectious Diseases. 16(12). 876–882. 12 indexed citations
18.
Muñoz, Francisco J., et al.. (1997). Pleural and peritoneal leishmaniasis in an AIDS patient. European Journal of Clinical Microbiology & Infectious Diseases. 16(3). 246–248. 13 indexed citations
19.
Gatell, JM, Josep Mallolas, Carmen Vidal, et al.. (1996). A pilot case-control study of zidovudine compared with zidovudine plus didanosine in patients with advanced HIV-1 disease and no previous experience with antiretrovirals.. PubMed. 1(2). 105–12. 2 indexed citations
20.
Torres, Antoní, M. El-Ebiary, Ramón M. Marrades, et al.. (1995). Aetiology and prognostic factors of patients with AIDS presenting life-threatening acute respiratory failure. European Respiratory Journal. 8(11). 1922–1928. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antoni Jou Breakdown of academic impact, for papers by Montserrat Tuset Breakdown of academic impact, for papers by Antonio Antela Breakdown of academic impact, for papers by Francesca Lombardi Breakdown of academic impact, for papers by N. Kumarasamy Breakdown of academic impact, for papers by Sean E Collins Breakdown of academic impact, for papers by Valerianna Amorosa Breakdown of academic impact, for papers by Maureen Wellington Breakdown of academic impact, for papers by Wisit Prasithsirikul Breakdown of academic impact, for papers by Bernardino Roca
Rankless by CCL
2026